Sign in

Publications

Search in 13351 publications:

Reset RSS
Time frame
314 Publication(s)
Jun 1, 2020
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:135.
Jun 1, 2020
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Jun 1, 2020

Radiat Oncol 2020; 15:135

Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias

more
May 22, 2020
Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise
Glatzer M, Belderbos J, Dziadziuszko R, Le Pechoux C, McDonald F, Nestle U, Peeters S, Pöttgen C, Ramella S, Slotman B, Dahele M, Troost E, Van Houtte P, Widder J, De Ruysscher D, Faivre-Finn C, Putora P. Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise. Radiother Oncol 2020; 150:26-29.
May 22, 2020
Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise
May 22, 2020

Radiother Oncol 2020; 150:26-29

Glatzer Markus, Belderbos Jose, Dziadziuszko Rafal, Le Pechoux Cecile, McDonald Fiona, Nestle Ursula, Peeters Stephanie T H, Pöttgen Christoph, Ramella Sara, Slotman Ben J, Dahele M R, Troost Esther G C, Van Houtte Paul, Widder Joachim, De Ruysscher Dirk, Faivre-Finn Corinne, Putora Paul Martin

more
May 19, 2020
Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
Iseli T, Plasswilm L, Sirén C, Schmidt B, Rothermundt C, Hundsberger T, Glatzer M, Panje C, Fischer G, Putora P. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
May 19, 2020
Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
May 19, 2020

Oncology 2020; 98:438-444

Iseli Thomas, Plasswilm Ludwig, Sirén Charlotta, Schmidt Barbara, Rothermundt Christian, Hundsberger Thomas, Glatzer Markus, Panje Cédric, Fischer Galina, Putora Paul Martin

more
May 14, 2020
Oncology Informatics: Status Quo and Outlook
Putora P, Baudis M, Beadle B, El Naqa I, Giordano F, Nicolay N. Oncology Informatics: Status Quo and Outlook. Oncology 2020; 98:329-331.
May 14, 2020
Oncology Informatics: Status Quo and Outlook
May 14, 2020

Oncology 2020; 98:329-331

Putora Paul Martin, Baudis Michael, Beadle Beth M, El Naqa Issam, Giordano Frank A, Nicolay Nils H

more
May 12, 2020
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
De Bruycker A, Guckenberger M, Heikkilä R, Putora P, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ameye F, Siva S, Shelan M, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte F, Papachristofilou A, Scorsetti M, Ost P. PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. BMC cancer 2020; 20:406.
May 12, 2020
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
May 12, 2020

BMC cancer 2020; 20:406

De Bruycker A, Guckenberger M, Heikkilä R, Putora Paul Martin, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ameye F, Siva S, Shelan M, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte F, Papachristofilou A, Scorsetti M, Ost P

more
Apr 24, 2020
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
Troost E, Nestle U, Putora P, Bussink J. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol 2020; 147:227-228.
Apr 24, 2020
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
Apr 24, 2020

Radiother Oncol 2020; 147:227-228

Troost Esther G C, Nestle Ursula, Putora Paul Martin, Bussink Johan

more
Apr 20, 2020
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
Putora P, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O'Brien M, Paz Ares L, de Marinis F, Westeel V, Widder J, Peeters S, Troost E, Fischer G, Früh M, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Péchoux C, Ramella S, Belderbos J, Slotman B, De Ruysscher D. Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts. Radiother Oncol 2020; 149:84-88.
Apr 20, 2020
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
Apr 20, 2020

Radiother Oncol 2020; 149:84-88

Putora Paul Martin, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O'Brien M, Paz Ares L, de Marinis F, Westeel V, Widder J, Peeters S, Troost E G C, Fischer G F, Früh Martin, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Péchoux C, Ramella S, Belderbos J, Slotman B J, De Ruysscher D

more
Mar 31, 2020
Choice of first line systemic treatment in pancreatic cancer among national experts
Glatzer M, Pless M, Pederiva S, Pestalozzi B, Berger M, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora P. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20 (2020):686-690.
Mar 31, 2020
Choice of first line systemic treatment in pancreatic cancer among national experts
Mar 31, 2020

Pancreatology 2020; 20 (2020):686-690

Glatzer Markus, Pless Miklos, Pederiva S., Pestalozzi Bernhard, Berger M.D., Inauen Roman, Winterhalder Ralf, Montemurro Michael, Horber Daniel, Putora Paul Martin

more
Mar 31, 2020
Choice of first line systemic treatment in pancreatic cancer among national experts
Glatzer M, Pless M, Pederiva S, Pestalozzi B, Berger M, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora P. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20:686-690.
Mar 31, 2020
Choice of first line systemic treatment in pancreatic cancer among national experts
Mar 31, 2020

Pancreatology 2020; 20:686-690

Glatzer Markus, Pless M, Pederiva S, Pestalozzi B, Berger M D, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora Paul Martin

more
Mar 30, 2020
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
Früh M, De Ruysscher D, Westeel V, de Marinis F, Paz Ares L, O'Brien M, Felip E, Garrido P, Novello S, Besse B, Cappuzzo F, Califano R, Blackhall F, Reck M, Panje C, Putora P. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts. Lung Cancer 2020; 146:6-11.
Mar 30, 2020
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
Mar 30, 2020

Lung Cancer 2020; 146:6-11

Früh Martin, De Ruysscher D, Westeel V, de Marinis F, Paz Ares L, O'Brien M, Felip E, Garrido P, Novello S, Besse B, Cappuzzo F, Califano R, Blackhall F, Reck M, Panje C M, Putora Paul Martin

more
Feb 12, 2020
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry
Viktorin-Baier P, Zürn K, Güsewell S, Schiefer J, Blick N, Müntener M, Stucki P, Suter S, Prikler L, Hochreiter W, Thoeni A, Schwab C, Plasswilm L, Schmid H, Putora P, Engeler D. Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry. BJU Int 2020; 125:827-835.
Feb 12, 2020
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry
Feb 12, 2020

BJU Int 2020; 125:827-835

Viktorin-Baier Pascal, Zürn Karin, Güsewell Sabine, Schiefer Johann, Blick Nadja, Müntener Michael, Stucki Patrick, Suter Stefan, Prikler Ladislav, Hochreiter Werner, Thoeni Armin, Schwab Christoph, Plasswilm Ludwig, Schmid Hans-Peter, Putora Paul Martin, Engeler Daniel

more
Jan 16, 2020
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland
Panje C, Schwenkglenks M, Gautschi O, Plasswilm L, Aebersold D, Dedes K, Lorez M, Pardo E, Barbier M, Lupatsch J, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Ann Oncol 2020; 31:501-506.
Jan 16, 2020
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland
Jan 16, 2020

Ann Oncol 2020; 31:501-506

Panje Cédric, Schwenkglenks M, Gautschi O, Plasswilm Ludwig, Aebersold D M, Dedes K J, Lorez M, Pardo E, Barbier M, Lupatsch J E, Swiss Group for Clinical Cancer Research (SAKK)

more
Jan 3, 2020
Emotions as Social Information in Shared Decision-Making in Oncology
Treffers T, Putora P. Emotions as Social Information in Shared Decision-Making in Oncology. Oncology 2020; 98:430-437.
Jan 3, 2020
Emotions as Social Information in Shared Decision-Making in Oncology
Jan 3, 2020

Oncology 2020; 98:430-437

Treffers Theresa, Putora Paul Martin

more
Jan 1, 2020
Langzeitresultate des prospektiven Schweizer Registers LDR-Brachytherapie des lokalisierten Prostatakarzinoms
Schmid H, Viktorin P, Putora P, Schiefer J, Schwab C, Plasswilm L, Engeler D. Langzeitresultate des prospektiven Schweizer Registers LDR-Brachytherapie des lokalisierten Prostatakarzinoms. German Medical Science, www.egms.de 2020
Jan 1, 2020
Langzeitresultate des prospektiven Schweizer Registers LDR-Brachytherapie des lokalisierten Prostatakarzinoms
Jan 1, 2020

German Medical Science, www.egms.de 2020

Schmid Hans-Peter, Viktorin P, Putora Paul Martin, Schiefer Johann, Schwab Christoph, Plasswilm Ludwig, Engeler Daniel

more
Dec 27, 2019
The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts
Putora P, Belderbos J, Dziadziuszko R, Le Pechoux C, McDonald F, Nestle U, Peeters S, Pöttgen C, Ramella S, Slotman B, Troost E, Van Houtte P, Widder J, Glatzer M, De Ruysscher D, Faivre-Finn C. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. Radiother Oncol 2019; 145:45-48.
Dec 27, 2019
The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts
Dec 27, 2019

Radiother Oncol 2019; 145:45-48

Putora Paul Martin, Belderbos Jose, Dziadziuszko Rafal, Le Pechoux Cecile, McDonald Fiona, Nestle Ursula, Peeters Stephanie, Pöttgen Christoph, Ramella Sara, Slotman Ben J, Troost Esther G C, Van Houtte Paul, Widder Joachim, Glatzer Markus, De Ruysscher Dirk, Faivre-Finn Corinne

more
Dec 27, 2019
Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland
Bhadhuri A, Insinga R, Guggisberg P, Panje C, Schwenkglenks M. Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland. Swiss Med Wkly 2019; 149:w20170.
Dec 27, 2019
Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland
Dec 27, 2019

Swiss Med Wkly 2019; 149:w20170

Bhadhuri Arjun, Insinga Ralph, Guggisberg Patrik, Panje Cédric, Schwenkglenks Matthias

more
Dec 13, 2019
Radiotherapie bei schmerzhaften Metastasen
Iseli T, Plasswilm L. Radiotherapie bei schmerzhaften Metastasen - Konzept und Vorgehen in der klinischen Praxis. Schweizerische Zeitschrift für Onkologie 2019; 5:17-20.
Dec 13, 2019
Radiotherapie bei schmerzhaften Metastasen
Dec 13, 2019

Schweizerische Zeitschrift für Onkologie 2019; 5:17-20

Iseli Thomas, Plasswilm Ludwig

more
Dec 2, 2019
Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
Panje C, Putora P, Hundsberger T, Hottinger A, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
Dec 2, 2019
Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
Dec 2, 2019

Swiss Med Wkly 2019; 149:w20153

Panje Cédric, Putora Paul Martin, Hundsberger Thomas, Hottinger Andreas F, Roelcke Ulrich, Pesce Gianfranco, Herrmann Evelyn, Matter-Walstra Klazien

more
Dec 1, 2019
Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]
Putora P, Nestle U, Novello S, O' Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E, Van Houtte P, Westeel V, Widder J, Mornex F, McDonald F, Le Pechoux C, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Slotman B. Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]. Radiother Oncol 2019; 141:332.
Dec 1, 2019
Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]
Dec 1, 2019

Radiother Oncol 2019; 141:332

Putora Paul Martin, Nestle Ursula, Novello Silvia, O' Brien Mary, Paz Ares Luis, Peeters Stephanie, Pöttgen Christoph, Ramella Sara, Reck Martin, Troost Esther G C, Van Houtte Paul, Westeel Virginie, Widder Joachim, Mornex Francoise, McDonald Fiona, Le Pechoux Cecile, Glatzer Markus, De Ruysscher Dirk, Faivre-Finn Corinne, Belderbos Jose, Besse Benjamin, Blackhall Fiona, Califano Raffaele, Cappuzzo Federico, de Marinis Filippo, Dziadiuszko Rafal, Felip Enriqueta, Früh Martin, Garrido Pilar, Slotman Ben J

more
Dec 1, 2019
Abscopal effect in lung cancer: three case reports and a concise review
Garelli E, Rittmeyer A, Putora P, Glatzer M, Dressel R, Andreas S. Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy 2019; 11:1445-1461.
Dec 1, 2019
Abscopal effect in lung cancer: three case reports and a concise review
Dec 1, 2019

Immunotherapy 2019; 11:1445-1461

Garelli Elena, Rittmeyer Achim, Putora Paul Martin, Glatzer Markus, Dressel Ralf, Andreas Stefan

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy